Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
81,025,132
-
Shares change
-
+2,614,259
-
Total reported value, excl. options
-
$3,295,908,701
-
Value change
-
+$98,098,293
-
Put/Call ratio
-
28%
-
Number of buys
-
113
-
Number of sells
-
-91
-
Price
-
$40.67
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2023
246 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2023.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81,025,132 shares
.
Largest 10 shareholders include FMR LLC (10,253,124 shares), VANGUARD GROUP INC (7,552,477 shares), RTW INVESTMENTS, LP (7,235,196 shares), BlackRock Inc. (6,866,343 shares), WELLINGTON MANAGEMENT GROUP LLP (6,786,364 shares), JANUS HENDERSON GROUP PLC (3,596,750 shares), FRANKLIN RESOURCES INC (3,311,904 shares), ARMISTICE CAPITAL, LLC (3,236,000 shares), STATE STREET CORP (3,170,484 shares), and Camber Capital Management LP (2,500,000 shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.